Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joseph, F. B.
Right arrow Articles by Bernardino, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joseph, F. B.
Right arrow Articles by Bernardino, M. E.

Radiology, Vol 186, 553-556, Copyright © 1993 by Radiological Society of North America


ARTICLES

Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy. Work in progress

FB Joseph, DA Baumgarten and ME Bernardino
Department of Radiology, Emory University School of Medicine, Atlanta, GA 30322.

Nine patients with biopsy-proved hepatocellular carcinoma underwent percutaneous ethanol ablation therapy (PEAT) with computed tomographic (CT) guidance. Twenty-five ablation sessions were performed in nine lesions ranging in size from 1.8 to 6.5 cm. Repeat biopsy was performed in seven of those nine lesions between 1 and 2 months after completion of therapy. CT scans obtained immediately after ablation demonstrated a necrotic area equal in size to the target lesion in five patients; four of those five patients have had negative findings at biopsy and are free of known disease. None of the patients with CT evidence of limited necrosis are currently free of disease. Peripheral nodularity was demonstrated after ablation in three patients at CT; none are free of disease. All four patients in whom there was no peripheral nodularity are free of known disease. Thus, CT evidence of necrosis and lack of nodularity immediately after PEAT are suggestive of absence of disease.


This article has been cited by other articles:


Home page
RadioGraphicsHome page
S. Ghai, D. K. Rajan, M. S. Benjamin, M. R. Asch, and S. Ghai
Uterine Artery Embolization for Leiomyomas: Pre- and Postprocedural Evaluation with US
RadioGraphics, September 1, 2005; 25(5): 1159 - 1172.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. K. Kim, H. K. Lim, Y. H. Kim, W. J. Lee, S. J. Lee, S. H. Kim, J. H. Lim, and S. A. Kim
Hepatocellular Carcinoma Treated with Radio-frequency Ablation: Spectrum of Imaging Findings
RadioGraphics, January 1, 2003; 23(1): 107 - 121.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. Dimitrakopoulou-Strauss, L. G. Strauss, F. Gutzler, G. Irngartinger, G. Kontaxakis, D. K. Kim, F. Oberdorfer, and G. van Kaick
Pharmacokinetic Imaging of 11C Ethanol with PET in Eight Patients with Hepatocellular Carcinomas Who Were Scheduled for Treatment with Percutaneous Ethanol Injection
Radiology, June 1, 1999; 211(3): 681 - 686.
[Abstract] [Full Text]


Home page
RadiologyHome page
H. K. Lim, D. Choi, W. J. Lee, S. H. Kim, S. J. Lee, H.-J. Jang, J.-H. Lee, J. H. Lim, and I. W. Choo
Hepatocellular Carcinoma Treated with Percutaneous Radio-frequency Ablation: Evaluation with Follow-up Multiphase Helical CT
Radiology, November 1, 2001; 221(2): 447 - 454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1993 by the Radiological Society of North America.